RxDoctor Payments DataLook up a doctor →

EXSERVAN: payments to doctors

Payments that named EXSERVAN as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$52K
Providers
635
Transactions
1,143
Average per transaction
$45

The per-transaction average — $45 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 635 providers the average total is $82, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Mitsubishi Tanabe Pharma America, Inc.$51,870100.0%
← All drugs & devices